🇫🇷
France · FR · FR:61602060
LENALIDOMIDE STRAGEN 2,5 mg, gélule
ATC L04AX04
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerSTRAGEN-FRANCE
CountryFR (France)
ATC codeL04AX04
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip133400930204917plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 21 gélule(s)
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "61602060",
"date_amm": "2020-05-11",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L04AX04.
Access this data programmatically
Query LENALIDOMIDE STRAGEN 2,5 mg, gélule and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.